5-hydroxydecanoate has been researched along with Left Ventricular Dysfunction in 2 studies
5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, H | 1 |
| Huang, X | 1 |
| Li, Q | 1 |
| Guan, Y | 1 |
| Yuan, F | 1 |
| Zhang, Y | 1 |
| Brown, DA | 1 |
| Chicco, AJ | 1 |
| Jew, KN | 1 |
| Johnson, MS | 1 |
| Lynch, JM | 1 |
| Watson, PA | 1 |
| Moore, RL | 1 |
2 other studies available for 5-hydroxydecanoate and Left Ventricular Dysfunction
| Article | Year |
|---|---|
ATP-dependent potassium channels and mitochondrial permeability transition pores play roles in the cardioprotection of theaflavin in young rat.
Topics: Animals; Atractyloside; Biflavonoids; Cardiotonic Agents; Catechin; Decanoic Acids; Glyburide; Heart | 2011 |
Cardioprotection afforded by chronic exercise is mediated by the sarcolemmal, and not the mitochondrial, isoform of the KATP channel in the rat.
Topics: Animals; ATP-Binding Cassette Transporters; Benzamides; Calcium; Decanoic Acids; Female; Heart; Hydr | 2005 |